{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:36:23Z","timestamp":1792092983378,"version":"4.4.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","award":["Graduate School Scholarship"],"award-info":[{"award-number":["Graduate School Scholarship"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","award":["Promoting Women Fellowship"],"award-info":[{"award-number":["Promoting Women Fellowship"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56361-4","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:05:59Z","timestamp":1781269559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bioinformatic pipeline to identify potential therapeutic targets with subsequent isolation and characterization of novel human anti- DDR1 antibodies"],"prefix":"10.1038","volume":"16","author":[{"given":"Divya","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag S.","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda F.","family":"Zacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"56361_CR1","unstructured":"Cancer Facts & Figures. American Cancer Society journal, CA: A Cancer Journal for Clinicians 2023; Available from: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2023-cancer-facts-figures.html."},{"key":"56361_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00868-x","volume":"7","author":"S Jin","year":"2022","unstructured":"Jin, S. et al. Emerging new therapeutic antibody derivatives for cancer treatment. Signal Transduct Target Ther 7, 39. https:\/\/doi.org\/10.1038\/s41392-021-00868-x (2022).","journal-title":"Signal Transduct Target Ther"},{"key":"56361_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antib7030030","author":"A Kizhedath","year":"2018","unstructured":"Kizhedath, A., Wilkinson, S. & Glassey, J. Applicability of traditional in vitro toxicity tests for assessing adverse effects of monoclonal antibodies: A case study of Rituximab and Trastuzumab. Antibodies https:\/\/doi.org\/10.3390\/antib7030030 (2018).","journal-title":"Antibodies"},{"key":"56361_CR4","doi-asserted-by":"publisher","unstructured":"Dall\u2019Ozzo, S., et al., Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship. Cancer Res. 64, 4664-9; https:\/\/doi.org\/10.1158\/0008-5472.CAN-03-2862 (2004).","DOI":"10.1158\/0008-5472.CAN-03-2862"},{"key":"56361_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/antib9030034","author":"D Zahavi","year":"2020","unstructured":"Zahavi, D. & Weiner, L. Monoclonal antibodies in cancer therapy. Antibodies https:\/\/doi.org\/10.3390\/antib9030034 (2020).","journal-title":"Antibodies"},{"key":"56361_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061660","author":"S Feola","year":"2020","unstructured":"Feola, S., Chiaro, J., Martins, B. & Cerullo, V. Uncovering the tumor antigen landscape: What to know about the discovery process. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12061660 (2020).","journal-title":"Cancers (Basel)"},{"key":"56361_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ijc.27679","volume":"132","author":"T Yokoyama","year":"2013","unstructured":"Yokoyama, T. et al. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer. Int J Cancer 132, 472\u2013484. https:\/\/doi.org\/10.1002\/ijc.27679 (2013).","journal-title":"Int J Cancer"},{"key":"56361_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1677\/erc.1.00766","volume":"11","author":"P Carter","year":"2004","unstructured":"Carter, P., Smith, L. & Ryan, M. Identification and validation of cell surface antigens for antibody targeting in oncology. Endocr. Relat. Cancer 11, 659\u201387. https:\/\/doi.org\/10.1677\/erc.1.00766 (2004).","journal-title":"Endocr. Relat. Cancer"},{"key":"56361_CR9","doi-asserted-by":"publisher","unstructured":"Cortes-Cros, M., T. Schmelzle, V.M. Stucke, and F. Hofmann, The path to oncology drug target validation: an industry perspective. Methods Mol Biol. 986, 3-13; https:\/\/doi.org\/10.1007\/978-1-62703-311-4_1 (2013).","DOI":"10.1007\/978-1-62703-311-4_1"},{"key":"56361_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1101\/sqb.2016.81.031096","volume":"81","author":"E Manchado","year":"2016","unstructured":"Manchado, E. et al. A pipeline for drug target identification and validation. Cold Spring Harb. Symp. Quant. Biol. 81, 257\u2013267. https:\/\/doi.org\/10.1101\/sqb.2016.81.031096 (2016).","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"56361_CR11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2206751120","volume":"120","author":"B Schrofelbauer","year":"2023","unstructured":"Schrofelbauer, B. et al. Discovery of antibodies and cognate surface targets for ovarian cancer by surface profiling. Proc. Natl. Acad. Sci. U. S. A. 120, e2206751120. https:\/\/doi.org\/10.1073\/pnas.2206751120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"56361_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01384-x","volume":"22","author":"B Zhou","year":"2024","unstructured":"Zhou, B. et al. Targeting the macrophage immunocheckpoint: A novel insight into solid tumor immunotherapy. Cell Commun. Signal. 22, 66. https:\/\/doi.org\/10.1186\/s12964-023-01384-x (2024).","journal-title":"Cell Commun. Signal."},{"key":"56361_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00447","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Changing technologies of RNA sequencing and their applications in clinical oncology. Front. Oncol. 10, 447. https:\/\/doi.org\/10.3389\/fonc.2020.00447 (2020).","journal-title":"Front. Oncol."},{"key":"56361_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-025-01518-5","volume":"17","author":"X Lu","year":"2025","unstructured":"Lu, X. et al. Cell-cell interactions as predictive and prognostic markers for drug responses in cancer. Genome Med. 17, 117. https:\/\/doi.org\/10.1186\/s13073-025-01518-5 (2025).","journal-title":"Genome Med."},{"key":"56361_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-9-117","volume":"4","author":"D Greenbaum","year":"2003","unstructured":"Greenbaum, D., Colangelo, C., Williams, K. & Gerstein, M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 4, 117. https:\/\/doi.org\/10.1186\/gb-2003-4-9-117 (2003).","journal-title":"Genome Biol."},{"key":"56361_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu, Y., Beyer, A. & Aebersold, R. On the dependency of cellular protein levels on mRNA abundance. Cell 165, 535\u201350. https:\/\/doi.org\/10.1016\/j.cell.2016.03.014 (2016).","journal-title":"Cell"},{"key":"56361_CR17","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188503","volume":"15","author":"D Wang","year":"2019","unstructured":"Wang, D. et al. A deep proteome and transcriptome abundance atlas of 29 healthy human tissues. Mol. Syst. Biol. 15, e8503. https:\/\/doi.org\/10.15252\/msb.20188503 (2019).","journal-title":"Mol. Syst. Biol."},{"key":"56361_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-11","volume":"12","author":"S Rust","year":"2013","unstructured":"Rust, S. et al. Combining phenotypic and proteomic approaches to identify membrane targets in a \u2018triple negative\u2019 breast cancer cell type. Mol. Cancer 12, 11. https:\/\/doi.org\/10.1186\/1476-4598-12-11 (2013).","journal-title":"Mol. Cancer"},{"key":"56361_CR19","doi-asserted-by":"publisher","unstructured":"Coarfa, C., et al., Reverse-Phase Protein Array: Technology, Application, Data Processing, and Integration. J Biomol Tech. 32, 15-29; https:\/\/doi.org\/10.7171\/jbt.21-3202-001 (2021).","DOI":"10.7171\/jbt.21-3202-001"},{"key":"56361_CR20","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.3892\/or.2019.7338","volume":"42","author":"X Zhong","year":"2019","unstructured":"Zhong, X., Zhang, W. & Sun, T. DDR1 promotes breast tumor growth by suppressing antitumor immunity. Oncol. Rep. 42, 2844\u20132854. https:\/\/doi.org\/10.3892\/or.2019.7338 (2019).","journal-title":"Oncol. Rep."},{"key":"56361_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188829","volume":"1878","author":"Y Tian","year":"2023","unstructured":"Tian, Y., Bai, F. & Zhang, D. New target DDR1: A \u201cdouble-edged sword\u201d in solid tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878, 188829. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188829 (2023).","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"56361_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ejphar.2008.10.014","volume":"599","author":"E Day","year":"2008","unstructured":"Day, E. et al. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by Imatinib, Nilotinib and Dasatinib. Eur. J. Pharmacol. 599, 44\u201353. https:\/\/doi.org\/10.1016\/j.ejphar.2008.10.014 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"56361_CR23","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1002\/1878-0261.12520","volume":"13","author":"Y Tao","year":"2019","unstructured":"Tao, Y. et al. Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma. Mol. Oncol. 13, 1855\u20131873. https:\/\/doi.org\/10.1002\/1878-0261.12520 (2019).","journal-title":"Mol. Oncol."},{"key":"56361_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.4149\/neo_2021_201126N1282","volume":"68","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Nilotinib, a discoidin domain receptor 1 (DDR1) inhibitor, induces apoptosis and inhibits migration in breast cancer. Neoplasma 68, 975\u2013982. https:\/\/doi.org\/10.4149\/neo_2021_201126N1282 (2021).","journal-title":"Neoplasma"},{"key":"56361_CR25","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1021\/cb400430t","volume":"8","author":"HG Kim","year":"2013","unstructured":"Kim, H. G. et al. Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor. ACS Chem. Biol. 8, 2145\u201350. https:\/\/doi.org\/10.1021\/cb400430t (2013).","journal-title":"ACS Chem. Biol."},{"key":"56361_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/13543776.2020.1732925","volume":"30","author":"J Guo","year":"2020","unstructured":"Guo, J., Zhang, Z. & Ding, K. A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present). Expert Opin. Ther. Pat. 30, 341\u2013350. https:\/\/doi.org\/10.1080\/13543776.2020.1732925 (2020).","journal-title":"Expert Opin. Ther. Pat."},{"key":"56361_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126535","author":"A Elkamhawy","year":"2021","unstructured":"Elkamhawy, A. et al. The journey of DDR1 and DDR2 kinase inhibitors as rising stars in the fight against cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22126535 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"56361_CR28","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.jmb.2014.04.014","volume":"426","author":"P Canning","year":"2014","unstructured":"Canning, P. et al. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors. J. Mol. Biol. 426, 2457\u201370. https:\/\/doi.org\/10.1016\/j.jmb.2014.04.014 (2014).","journal-title":"J. Mol. Biol."},{"key":"56361_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11060-005-6874-1","volume":"76","author":"R Ram","year":"2006","unstructured":"Ram, R. et al. Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. J. Neurooncol. 76, 239\u201348. https:\/\/doi.org\/10.1007\/s11060-005-6874-1 (2006).","journal-title":"J. Neurooncol."},{"key":"56361_CR30","doi-asserted-by":"publisher","first-page":"6905","DOI":"10.1158\/1078-0432.CCR-11-0288","volume":"17","author":"RS Finn","year":"2011","unstructured":"Finn, R. S. et al. Dasatinib as a single agent in triple-negative breast cancer: Results of an open-label phase 2 study. Clin. Cancer Res. 17, 6905\u201313. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0288 (2011).","journal-title":"Clin. Cancer Res."},{"key":"56361_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103975","volume":"29","author":"D Wu","year":"2024","unstructured":"Wu, D. et al. DDR1-targeted therapies: Current limitations and future potential. Drug Discov. Today 29, 103975. https:\/\/doi.org\/10.1016\/j.drudis.2024.103975 (2024).","journal-title":"Drug Discov. Today"},{"key":"56361_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel, C. & Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227\u201332. https:\/\/doi.org\/10.1038\/nrg3185 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"56361_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tibs.2014.10.010","volume":"40","author":"SH Payne","year":"2015","unstructured":"Payne, S. H. The utility of protein and mRNA correlation. Trends Biochem. Sci. 40, 1\u20133. https:\/\/doi.org\/10.1016\/j.tibs.2014.10.010 (2015).","journal-title":"Trends Biochem. Sci."},{"key":"56361_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJM199207303270505","volume":"327","author":"JR Harris","year":"1992","unstructured":"Harris, J. R., Lippman, M. E., Veronesi, U. & Willett, W. Breast cancer (1). N. Engl. J. Med. 327, 319\u201328. https:\/\/doi.org\/10.1056\/NEJM199207303270505 (1992).","journal-title":"N. Engl. J. Med."},{"key":"56361_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep20567","volume":"6","author":"X Huang","year":"2016","unstructured":"Huang, X., Stern, D. F. & Zhao, H. Transcriptional profiles from paired normal samples offer complementary information on cancer patient survival--Evidence from TCGA pan-cancer data. Sci. Rep. 6, 20567. https:\/\/doi.org\/10.1038\/srep20567 (2016).","journal-title":"Sci. Rep."},{"key":"56361_CR36","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17295","author":"S Hu","year":"2017","unstructured":"Hu, S. et al. Transcriptional response profiles of paired tumor-normal samples offer novel perspectives in pan-cancer analysis. Oncotarget https:\/\/doi.org\/10.18632\/oncotarget.17295 (2017).","journal-title":"Oncotarget"},{"key":"56361_CR37","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.8987.2","volume":"5","author":"Y Chen","year":"2016","unstructured":"Chen, Y., Lun, A. T. & Smyth, G. K. From reads to genes to pathways: Differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Res. 5, 1438. https:\/\/doi.org\/10.12688\/f1000research.8987.2 (2016).","journal-title":"F1000Res."},{"key":"56361_CR38","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47\u2013e47. https:\/\/doi.org\/10.1093\/nar\/gkv007 (2015).","journal-title":"Nucleic Acids Res."},{"key":"56361_CR39","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41588-020-0669-3","volume":"52","author":"EA Bruford","year":"2020","unstructured":"Bruford, E. A. et al. Guidelines for human gene nomenclature. Nat. Genet. 52, 754\u2013758. https:\/\/doi.org\/10.1038\/s41588-020-0669-3 (2020).","journal-title":"Nat. Genet."},{"key":"56361_CR40","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592. https:\/\/doi.org\/10.1093\/nar\/gkac963 (2023).","journal-title":"Nucleic Acids Res."},{"key":"56361_CR41","doi-asserted-by":"publisher","unstructured":"Gene Ontology, C., et al., The Gene Ontology knowledgebase in 2023. Genetics. 224; https:\/\/doi.org\/10.1093\/genetics\/iyad031 (2023).","DOI":"10.1093\/genetics\/iyad031"},{"key":"56361_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","volume":"173","author":"F Sanchez-Vega","year":"2018","unstructured":"Sanchez-Vega, F. et al. Oncogenic signaling pathways in The Cancer Genome Atlas. Cell 173, 321-337.e10. https:\/\/doi.org\/10.1016\/j.cell.2018.03.035 (2018).","journal-title":"Cell"},{"key":"56361_CR43","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1373\/clinchem.2014.231712","volume":"61","author":"X Zhao","year":"2015","unstructured":"Zhao, X., Modur, V., Carayannopoulos, L. N. & Laterza, O. F. Biomarkers in pharmaceutical research. Clin. Chem. 61, 1343\u20131353. https:\/\/doi.org\/10.1373\/clinchem.2014.231712 (2015).","journal-title":"Clin. Chem."},{"key":"56361_CR44","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/s1097-2765(01)00318-5","volume":"8","author":"JD Schrag","year":"2001","unstructured":"Schrag, J. D. et al. The structure of calnexin, an ER chaperone involved in quality control of protein folding. Mol. Cell 8, 633\u201344. https:\/\/doi.org\/10.1016\/s1097-2765(01)00318-5 (2001).","journal-title":"Mol. Cell"},{"key":"56361_CR45","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/onc.2012.494","volume":"32","author":"J Zhao","year":"2013","unstructured":"Zhao, J. et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 32, 4814\u201324. https:\/\/doi.org\/10.1038\/onc.2012.494 (2013).","journal-title":"Oncogene"},{"key":"56361_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01570-w","volume":"8","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Endoplasmic reticulum stress: Molecular mechanism and therapeutic targets. Signal Transduct. Target. Ther. 8, 352. https:\/\/doi.org\/10.1038\/s41392-023-01570-w (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"56361_CR47","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1073\/pnas.91.14.6458","volume":"91","author":"Y Kawakami","year":"1994","unstructured":"Kawakami, Y. et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. U. S. A. 91, 6458\u201362. https:\/\/doi.org\/10.1073\/pnas.91.14.6458 (1994).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"56361_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41586-019-1006-9","volume":"567","author":"X Gui","year":"2019","unstructured":"Gui, X. et al. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway. Nature 567, 262\u2013266. https:\/\/doi.org\/10.1038\/s41586-019-1006-9 (2019).","journal-title":"Nature"},{"key":"56361_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbcan.2014.03.006","volume":"1846","author":"X Wang","year":"2014","unstructured":"Wang, X. & Li, S. Protein mislocalization: Mechanisms, functions and clinical applications in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846, 13\u201325. https:\/\/doi.org\/10.1016\/j.bbcan.2014.03.006 (2014).","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"56361_CR50","doi-asserted-by":"publisher","first-page":"D1398","DOI":"10.1093\/nar\/gkab953","volume":"50","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. Therapeutic target database update 2022: Facilitating drug discovery with enriched comparative data of targeted agents. Nucleic Acids Res. 50, D1398-d1407. https:\/\/doi.org\/10.1093\/nar\/gkab953 (2022).","journal-title":"Nucleic Acids Res."},{"key":"56361_CR51","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074-d1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037 (2018).","journal-title":"Nucleic Acids Res."},{"key":"56361_CR52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209563119","volume":"119","author":"DS Micalizzi","year":"2022","unstructured":"Micalizzi, D. S. et al. Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody. Proc. Natl. Acad. Sci. U. S. A. 119, e2209563119. https:\/\/doi.org\/10.1073\/pnas.2209563119 (2022).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"56361_CR53","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.str.2012.02.011","volume":"20","author":"F Carafoli","year":"2012","unstructured":"Carafoli, F. et al. Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling. Structure 20, 688\u201397. https:\/\/doi.org\/10.1016\/j.str.2012.02.011 (2012).","journal-title":"Structure"},{"key":"56361_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006720","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2023-006720 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"56361_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep26240","volume":"6","author":"ML Jones","year":"2016","unstructured":"Jones, M. L. et al. Targeting membrane proteins for antibody discovery using phage display. Sci. Rep. 6, 26240. https:\/\/doi.org\/10.1038\/srep26240 (2016).","journal-title":"Sci. Rep."},{"key":"56361_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413650","volume":"25","author":"B Perera","year":"2024","unstructured":"Perera, B. et al. Isolation and characterization of antibodies against Vascular Cell Adhesion Molecule-1 reveals putative role for Ig-like domains 2 and 3 in cell-to-cell interaction. Int. J. Mol. Sci. 25, 13650. https:\/\/doi.org\/10.3390\/ijms252413650 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"56361_CR57","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1046\/j.1432-1327.1999.00214.x","volume":"260","author":"HR Hoogenboom","year":"1999","unstructured":"Hoogenboom, H. R. et al. Selection\u2010dominant and nonaccessible epitopes on cell\u2010surface receptors revealed by cell\u2010panning with a large phage antibody library. Eur. J. Biochem. 260, 774\u2013784. https:\/\/doi.org\/10.1046\/j.1432-1327.1999.00214.x (1999).","journal-title":"Eur. J. Biochem."},{"key":"56361_CR58","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/14789450.2019.1645604","volume":"16","author":"DA Scott","year":"2019","unstructured":"Scott, D. A. & Drake, R. R. Glycosylation and its implications in breast cancer. Expert Rev. Proteomics. 16, 665\u2013680. https:\/\/doi.org\/10.1080\/14789450.2019.1645604 (2019).","journal-title":"Expert Rev. Proteomics."},{"key":"56361_CR59","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/s41556-020-00590-w","volume":"22","author":"M Ros","year":"2020","unstructured":"Ros, M. et al. ER-resident oxidoreductases are glycosylated and trafficked to the cell surface to promote matrix degradation by tumour cells. Nat. Cell Biol. 22, 1371\u20131381. https:\/\/doi.org\/10.1038\/s41556-020-00590-w (2020).","journal-title":"Nat. Cell Biol."},{"key":"56361_CR60","doi-asserted-by":"publisher","unstructured":"Joshi, H.J. and R. Gupta, Eukaryotic glycosylation: online methods for site prediction on protein sequences. Methods Mol Biol. 1273, 127-37; https:\/\/doi.org\/10.1007\/978-1-4939-2343-4_9 (2015).","DOI":"10.1007\/978-1-4939-2343-4_9"},{"key":"56361_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00832","volume":"8","author":"NB Crux","year":"2017","unstructured":"Crux, N. B. & Elahi, S. Human Leukocyte Antigen (HLA) and immune regulation: How do classical and non-classical HLA alleles modulate immune response to Human Immunodeficiency Virus and Hepatitis C Virus infections?. Front. Immunol. 8, 832. https:\/\/doi.org\/10.3389\/fimmu.2017.00832 (2017).","journal-title":"Front. Immunol."},{"key":"56361_CR62","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013W102. https:\/\/doi.org\/10.1093\/nar\/gkx247 (2017).","journal-title":"Nucleic Acids Res."},{"key":"56361_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00299-4","volume":"9","author":"E Burandt","year":"2021","unstructured":"Burandt, E. et al. E-Cadherin expression in human tumors: A tissue microarray study on 10,851 tumors. Biomark. Res. 9, 44. https:\/\/doi.org\/10.1186\/s40364-021-00299-4 (2021).","journal-title":"Biomark. Res."},{"key":"56361_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-015-3285-7","volume":"150","author":"KA Toy","year":"2015","unstructured":"Toy, K. A. et al. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer. Breast Cancer Res. Treat. 150, 9\u201318. https:\/\/doi.org\/10.1007\/s10549-015-3285-7 (2015).","journal-title":"Breast Cancer Res. Treat."},{"key":"56361_CR65","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/978-1-4939-8648-4_10","volume-title":"Methods Mol Biol.","author":"ML Jones","year":"2018","unstructured":"Jones, M. L., Mahler, S. M. & Kumble, S. Selection of antibodies to transiently expressed membrane proteins using phage display. In Methods Mol Biol. Vol. 1827 179\u2013195 (2018). https:\/\/doi.org\/10.1007\/978-1-4939-8648-4_10."},{"key":"56361_CR66","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.str.2014.11.010","volume":"23","author":"BD Weitzner","year":"2015","unstructured":"Weitzner, B. D., Dunbrack, R. L. Jr. & Gray, J. J. The origin of CDR H3 structural diversity. Structure 23, 302\u201311. https:\/\/doi.org\/10.1016\/j.str.2014.11.010 (2015).","journal-title":"Structure"},{"key":"56361_CR67","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jim.2010.02.001","volume":"354","author":"ML Jones","year":"2010","unstructured":"Jones, M. L. et al. A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies. J. Immunol. Methods 354, 85\u201390. https:\/\/doi.org\/10.1016\/j.jim.2010.02.001 (2010).","journal-title":"J. Immunol. Methods"},{"key":"56361_CR68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pep.2011.02.008","volume":"78","author":"F Bollin","year":"2011","unstructured":"Bollin, F., Dechavanne, V. & Chevalet, L. Design of experiment in CHO and HEK transient transfection condition optimization. Protein Expr. Purif. 78, 61\u20138. https:\/\/doi.org\/10.1016\/j.pep.2011.02.008 (2011).","journal-title":"Protein Expr. Purif."},{"key":"56361_CR69","doi-asserted-by":"publisher","first-page":"43248","DOI":"10.18632\/oncotarget.18020","volume":"8","author":"V Vella","year":"2017","unstructured":"Vella, V. et al. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells. Oncotarget 8, 43248\u201343270. https:\/\/doi.org\/10.18632\/oncotarget.18020 (2017).","journal-title":"Oncotarget"},{"key":"56361_CR70","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1172\/JCI10720","volume":"107","author":"G Hou","year":"2001","unstructured":"Hou, G., Vogel, W. & Bendeck, M. P. The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. J. Clin. Invest. 107, 727\u201335. https:\/\/doi.org\/10.1172\/JCI10720 (2001).","journal-title":"J. Clin. Invest."},{"key":"56361_CR71","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1002\/bit.27811","volume":"118","author":"F Klingler","year":"2021","unstructured":"Klingler, F. et al. Unveiling the CHO surfaceome: Identification of cell surface proteins reveals cell aggregation-relevant mechanisms. Biotechnol. Bioeng. 118, 3015\u20133028. https:\/\/doi.org\/10.1002\/bit.27811 (2021).","journal-title":"Biotechnol. Bioeng."},{"key":"56361_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01074","author":"A Geller","year":"2019","unstructured":"Geller, A. & Yan, J. The role of membrane bound complement regulatory proteins in tumor development and cancer immunotherapy. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01074 (2019).","journal-title":"Front. Immunol."},{"key":"56361_CR73","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/abt\/tby002","volume":"1","author":"D Zahavi","year":"2018","unstructured":"Zahavi, D., AlDeghaither, D., O\u2019Connell, A. & Weiner, L. M. Enhancing antibody-dependent cell-mediated cytotoxicity: A strategy for improving antibody-based immunotherapy. Antibody Ther. 1, 7\u201312. https:\/\/doi.org\/10.1093\/abt\/tby002 (2018).","journal-title":"Antibody Ther."},{"key":"56361_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlife.2024.01.003","author":"S Bibi","year":"2024","unstructured":"Bibi, S. et al. Discoidin domain receptor 1 as a potent therapeutic target in solid tumors. hLife https:\/\/doi.org\/10.1016\/j.hlife.2024.01.003 (2024).","journal-title":"hLife"},{"key":"56361_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","volume":"20","author":"T Stuart","year":"2019","unstructured":"Stuart, T. & Satija, R. Integrative single-cell analysis. Nat. Rev. Genet. 20, 257\u2013272. https:\/\/doi.org\/10.1038\/s41576-019-0093-7 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"56361_CR76","doi-asserted-by":"publisher","first-page":"E10988","DOI":"10.1073\/pnas.1808790115","volume":"115","author":"D Bausch-Fluck","year":"2018","unstructured":"Bausch-Fluck, D. et al. The in silico human surfaceome. Proc. Natl. Acad. Sci. U. S. A. 115, E10988\u2013E10997. https:\/\/doi.org\/10.1073\/pnas.1808790115 (2018).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"56361_CR77","doi-asserted-by":"publisher","first-page":"16752","DOI":"10.1073\/pnas.0907939106","volume":"106","author":"JP da Cunha","year":"2009","unstructured":"da Cunha, J. P. et al. Bioinformatics construction of the human cell surfaceome. Proc. Natl. Acad. Sci. U. S. A. 106, 16752\u20137. https:\/\/doi.org\/10.1073\/pnas.0907939106 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"56361_CR78","doi-asserted-by":"publisher","unstructured":"da Cunha, J.P., et al., The human cell surfaceome of breast tumors. Biomed Res Int. 2013, 976816; https:\/\/doi.org\/10.1155\/2013\/976816 (2013).","DOI":"10.1155\/2013\/976816"},{"key":"56361_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85256-9","volume":"11","author":"J Gonzalez Bosquet","year":"2021","unstructured":"Gonzalez Bosquet, J. et al. Creation and validation of models to predict response to primary treatment in serous ovarian cancer. Sci. Rep. 11, 5957. https:\/\/doi.org\/10.1038\/s41598-021-85256-9 (2021).","journal-title":"Sci. Rep."},{"key":"56361_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-27975-9","volume":"13","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance. Sci. Rep. 13, 5779. https:\/\/doi.org\/10.1038\/s41598-023-27975-9 (2023).","journal-title":"Sci. Rep."},{"key":"56361_CR81","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","volume":"8","author":"F Nimmerjahn","year":"2008","unstructured":"Nimmerjahn, F. & Ravetch, J. V. Fc\u03b3 receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34\u201347. https:\/\/doi.org\/10.1038\/nri2206 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"56361_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25. https:\/\/doi.org\/10.1186\/gb-2010-11-3-r25 (2010).","journal-title":"Genome Biol."},{"key":"56361_CR83","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185\u201393. https:\/\/doi.org\/10.1093\/bioinformatics\/19.2.185 (2003).","journal-title":"Bioinformatics"},{"key":"56361_CR84","doi-asserted-by":"crossref","unstructured":"Haynes, W., Benjamini\u2013Hochberg Method, in Encyclopedia of Systems Biology, W. Dubitzky, O. Wolkenhauer, K.-H. Cho, and H. Yokota, Editors. 2013, Springer New York: New York, NY. p. 78-78.","DOI":"10.1007\/978-1-4419-9863-7_1215"},{"key":"56361_CR85","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-981-16-5812-9_2","volume-title":"Practical Guide to Life Science Databases","author":"M Safran","year":"2021","unstructured":"Safran, M. et al. The GeneCards Suite. In Practical Guide to Life Science Databases (eds Abugessaisa, I. & Kasukawa, T.) 27\u201356 (Springer Nature Singapore, 2021)."},{"key":"56361_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158470","author":"N Panagides","year":"2022","unstructured":"Panagides, N. et al. Evaluation of phage display biopanning strategies for the selection of anti-cell surface receptor antibodies. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23158470 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"56361_CR87","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymben.2022.03.009","volume":"72","author":"M Malm","year":"2022","unstructured":"Malm, M. et al. Harnessing secretory pathway differences between HEK293 and CHO to rescue production of difficult to express proteins. Metab. Eng. 72, 171\u2013187. https:\/\/doi.org\/10.1016\/j.ymben.2022.03.009 (2022).","journal-title":"Metab. Eng."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56361-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56361-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56361-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:00:22Z","timestamp":1787785222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56361-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56361"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56361-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The healthy volunteers for donating blood samples were approved by the IIT Delhi Institute Ethics Committee under approval no. VS-0825-REA78. All patient data included in this study was obtained from Genomic Data Commons (GDC)-TCGA open access data tier. All samples are de-identified and have been collected and utilized following strict human subject protection guidelines and Institutional Review Board review of protocols.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26853"}}